These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2831361)

  • 1. Structure-activity relationships for drugs binding to the agonist and antagonist states of the primary morphine receptor.
    Cheney BV
    J Med Chem; 1988 Mar; 31(3):521-31. PubMed ID: 2831361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl]benzamides at the primary morphine receptor.
    Cheney BV; Szmuszkovicz J; Lahti RA; Zichi DA
    J Med Chem; 1985 Dec; 28(12):1853-64. PubMed ID: 2999404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structure-activity relationship of synthetic and semisynthetic opioid agonists and antagonists].
    Hosztafi S; Friedmann T; Furst Z
    Acta Pharm Hung; 1993 Nov; 63(6):335-49. PubMed ID: 8116454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonists.
    Feinberg AP; Creese I; Snyder SH
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4215-9. PubMed ID: 186791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of binding at the opioid receptor based upon an agonist/antagonist two-state model.
    Cheney BV; Lahti RA; Barsuhn C; Gay DD
    Mol Pharmacol; 1982 Sep; 22(2):349-59. PubMed ID: 6292693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic evidence for differential agonist and antagonist binding to bovine hippocampal synaptic membrane opioid receptors.
    Scheibe SD; Bennett DB; Spain JW; Roth BL; Coscia CJ
    J Biol Chem; 1984 Nov; 259(21):13298-303. PubMed ID: 6092373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanine nucleotides differentiate agonist and antagonist interactions with opiate receptors.
    Childers SR; Snyder SH
    Life Sci; 1978 Aug; 23(7):759-61. PubMed ID: 211364
    [No Abstract]   [Full Text] [Related]  

  • 8. Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors.
    Portoghese PS; Larson DL; Sayre LM; Yim CB; Ronsisvalle G; Tam SW; Takemori AE
    J Med Chem; 1986 Oct; 29(10):1855-61. PubMed ID: 3020244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of humoral endorphin on the binding of opiate agonists and antagonists.
    Sarne Y; Itzhak Y; Keren O
    Eur J Pharmacol; 1982 Jul; 81(2):227-35. PubMed ID: 6288405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantum chemical studies of molecular features and receptor interactions that modulate opiate agonist and antagonist activity.
    Burt SK; Loew GH; Hashimoto GM
    Ann N Y Acad Sci; 1981; 367():219-39. PubMed ID: 6266317
    [No Abstract]   [Full Text] [Related]  

  • 11. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.
    Valentino RJ; Katz JL; Medzihradsky F; Woods JH
    Life Sci; 1983 Jun; 32(25):2887-96. PubMed ID: 6304445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Narcotic binding to membrane acidic lipids.
    Loh HH; Cho TM; Cho JS; Way EL
    Prog Clin Biol Res; 1979; 27():27-49. PubMed ID: 218232
    [No Abstract]   [Full Text] [Related]  

  • 13. Affinities of opiate agonists and antagonists for the enkephalin receptors of rat brain.
    Wong DT; Horng JS
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):749-52. PubMed ID: 193169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of opiate agonist and antagonist receptor binding by protein modifying reagents.
    Wilson HA; Pasternak GW; Snyder SH
    Nature; 1975 Feb; 253(5491):448-50. PubMed ID: 46111
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel comprehensive opiate-receptor model.
    Kolb VM; Snyder JP
    NIDA Res Monogr; 1986; 75():41-4. PubMed ID: 2828987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding and analgesic properties of a sigma opiate, SKF 10,047.
    Pasternak GW; Carroll-Buatti M; Spiegel K
    J Pharmacol Exp Ther; 1981 Oct; 219(1):192-8. PubMed ID: 6270299
    [No Abstract]   [Full Text] [Related]  

  • 18. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B; Meng F; Akil H
    Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A steric theory of opioid agonists, antagonists, agonist-antagonists, and partial agonists.
    Martin WR
    NIDA Res Monogr; 1984 Mar; 49():16-23. PubMed ID: 6090916
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure-activity studies of narcotic agonists and antagonists from quantum chemical calculations.
    Loew GH; Berkowitz DS; Burt SK
    NIDA Res Monogr; 1978; (22):278-316. PubMed ID: 213725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.